We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYTS icon
2226
LSI Industries
LYTS
$890M
$42K ﹤0.01%
2,901
– –
NUVB icon
2227
Nuvation Bio
NUVB
$2.14B
$42K ﹤0.01%
14,367
– –
CCNE icon
2228
CNB Financial Corp
CCNE
$1.04B
$41.8K ﹤0.01%
2,047
– –
OUST icon
2229
Ouster
OUST
$3.25B
$41.7K ﹤0.01%
+4,239
New +$42.9K
CYH icon
2230
Community Health Systems
CYH
$410M
$41.7K ﹤0.01%
12,400
– –
SBGI icon
2231
Sinclair Inc
SBGI
$1B
$41.7K ﹤0.01%
3,125
– –
SRI icon
2232
Stoneridge
SRI
$197M
$41.4K ﹤0.01%
2,594
– –
ALX
2233
Alexander's
ALX
$1.39B
$41.4K ﹤0.01%
184
– –
HUMA icon
2234
Humacyte
HUMA
$148M
$41.3K ﹤0.01%
8,612
+3,908
+83% +$20.3K
CWCO icon
2235
Consolidated Water Co
CWCO
$505M
$41.3K ﹤0.01%
1,557
– –
ESPR
2236
DELISTED
Esperion Therapeutics
ESPR
$41.1K ﹤0.01%
+18,512
New +$43.5K
SPRY icon
2237
ARS Pharmaceuticals
SPRY
$606M
$41K ﹤0.01%
4,821
+2,819
+141% +$25K
BATRA icon
2238
Atlanta Braves Holdings Series A
BATRA
$3.63B
$41K ﹤0.01%
991
– –
ADPT icon
2239
Adaptive Biotechnologies
ADPT
$3.89B
$40.9K ﹤0.01%
11,286
– –
ADTN icon
2240
Adtran
ADTN
$665M
$40.8K ﹤0.01%
7,756
– –
SD icon
2241
SandRidge Energy
SD
$529M
$40.7K ﹤0.01%
3,148
– –
SB icon
2242
Safe Bulkers
SB
$760M
$40.6K ﹤0.01%
6,968
– –
CLDT
2243
Chatham Lodging
CLDT
$590M
$40.5K ﹤0.01%
4,756
– –
AIOT
2244
PowerFleet Inc
AIOT
$421M
$40.5K ﹤0.01%
+8,866
New +$42.1K
OSG
2245
DELISTED
Overseas Shipholding Group Inc.
OSG
$40.4K ﹤0.01%
4,767
– –
FMAY icon
2246
FT Vest US Equity Buffer ETF May
FMAY
$1.46B
$40.4K ﹤0.01%
905
– –
LAZR
2247
DELISTED
Luminar Technologies
LAZR
$40.3K ﹤0.01%
1,805
– –
GIC icon
2248
Global Industrial
GIC
$1.49B
$40.3K ﹤0.01%
1,285
– –
SHYF
2249
DELISTED
The Shyft Group
SHYF
$40.3K ﹤0.01%
3,397
– –
HRTX icon
2250
Heron Therapeutics
HRTX
$63.5M
$40.3K ﹤0.01%
11,502
+4,374
+61% +$13.4K
88 89
90
91 92

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.